Abstract
Chromium(VI) ‘Cr(VI)’ and cadmium (Cd) compounds are ubiquitous environmental carcinogens that have been associated with lung tumors and can induce apoptosis in various cell types. Three major mitogen‐activation protein kinases (MAPKs), extracellular signal‐regulated kinase (ERK), c‐JUN N‐terminal kinase (JNK) and p38, have been shown to regulate apoptosis. In this study we explore the abilities of Cr(VI) and Cd to activate JNK, p38 and ERK, including their roles in metal‐mediated growth inhibition and apoptosis in a human non‐small‐cell lung carcinoma cell line, CL3. Exposure to K2Cr2O7 markedly activated JNK and p38 and moderately activated ERK in a dose‐ and time‐dependent manner. The activated p38 decreased markedly and rapidly and the activated JNK decreased gradually when Cr(VI) was removed from media. At low cytotoxic doses, CdCl2 decreased ERK activity with concurrently transient activation of JNK, whereas at high cytotoxic doses it persistently activated all three MAPKs. The strength and duration of JNK and p38 activated by Cd were higher and longer than Cr(VI) did when compared at similar cytotoxic doses. In comparable experiment conditions Cd is a much stronger apoptotic inducer than Cr(VI) in CL3 cells. Cross‐talk of MAPKs was observed in cells exposed to Cr(VI) but not Cd. Both metals could increase JNK activity through MKK7 but not MKK4. The Cd‐activated JNK is involved in apoptosis, but the Cr‐activated JNK is not. PD98059, an inhibitor of the ERK upstream activators MKK1/2, greatly enhanced the cytotoxicity and apoptosis of cells treated with low Cd doses. SB202190, an inhibitor of p38, decreased the cytotoxicity and apoptosis induced by high Cd doses. Conversely, neither SB202190 nor PD98059 altered Cr(VI)‐induced cytotoxicity. The results suggest that JNK and p38 signals cooperatively participate in apoptosis induced by Cd and that the decreased ERK signal by low Cd doses contributes to growth inhibition or apoptosis. Oppositely, activation of ERK, JNK and p38 by Cr(VI) does not affect cytotoxicity.
Similar content being viewed by others
Reference
Marshall CJ: Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80: 179–185, 1995
Whitmarsh AJ, Davis RJ: Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways. J Mol Med 74: 589–607, 1996
Ip YT, Davis RJ: Signal transduction by the c-Jun N-terminal kinase (JNK)-from inflammation to development. Curr Opin Cell Biol 10: 205–219, 1998
Garrington TP, Johnson GL: Organization and regulation of mitogenactivated protein kinase signaling pathways. Curr Opin Cell Biol 11: 211–218, 1999
Nebreda AR, Porras A: p38 MAP kinases: Beyond the stress response. Trends Biochem Sci 25: 257–260, 2000
Hill CS, Treisman R: Transcriptional regulation by extracellular signals: Mechanisms and specificity. Cell 80: 199–211, 1995
IARC: Chromium, nickel, and wedding. In: IARC Monographs on the Evaluation of the Carcinogenic Risks of Chemicals to Humans, vol 19. International Agency for Cancer Research, Lyon, 1990
IARC: Cadmium and cadmium compounds. In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Cadmium, Mercury, Beryllium and Exposures in the Glass Industry, vol. 58. International Agency for Research on Cancer, Lyon, 1993, pp 119–237
Degraeve N: Carcinogenic, teratogenic and mutagenic effects of cadmium. Mutat Res 86: 115–135, 1981
Wetterhahn KE, Hamilton JW, Aiyar J, Borges KM, Floyd R: Mechanism of chromium(VI) carcinogenesis: Reactive intermediates and effect on gene expression. Biol Trace Element Res 21: 405–411, 1989
Shi X, Chiu A, Chen CT, Halliwell B, Castranova V, Vallyathan V: Reduction of chromium(VI) and its relationship to carcinogenesis. J Toxicol Environ Health B Crit Rev 2: 87–104, 1999
Ochi T, Ohsawa M: Participation of active oxygen species in the induction of chromosomal aberrations by cadmium chloride in cultured Chinese hamster cells. Mutat Res 143: 137–142, 1985
Yang JL, Chao JI, Lin JG: Reactive oxygen species may participate in the mutagenicity and mutational spectrum of cadmium in Chinese hamster ovary-K1 cells. Chem Res Toxicol 9: 1360–1367, 1996
Hwua YS, Yang JL: Effect of 3-aminotriazole on anchorage independence and mutagenicity in cadmium-and lead-treated diploid human fibroblasts. Carcinogenesis 19: 881–888, 1998
Ye J, Wang S, Leonard SS, Sun Y, Butterworth L, Antonini J, Ding M, Rojanasakul Y, Vallyathan V, Castranova V, Shi X: Role of reactive oxygen species and p53 in chromium(VI)-induced apoptosis. J Biol Chem 274: 34974–34980, 1999
Pritchard DE, Singh J, Carlisle DL, Patierno SR: Cyclosporin A inhibits chromium(VI)-induced apoptosis and mitochondrial cytochrome c release and restores clonogenic survival in CHO cells. Carcinogenesis 21: 2027–2033, 2000
Carlisle DL, Pritchard DE, Singh J, Patierno SR: Chromium(VI) induces p53-dependent apoptosis in diploid human lung and mouse dermal fibroblasts. Mol Carcinogen 28: 111–118, 2000
Galan A, Garcia-Bermejo ML, Troyano A, Vilaboa NE, de Blas E, Kazanietz MG, Aller P: Stimulation of p38 mitogen-activated protein kinase is an early regulatory event for the cadmium-induced apoptosis in human promonocytic cells. J Biol Chem 275: 11418–11424, 2000
Robertson JD, Orrenius S: Molecular mechanisms of apoptosis induced by cytotoxic chemicals. Crit Rev Toxicol 30: 609–627, 2000
Kim G, Yurkow EJ: Chromium induces a persistent activation of mitogen-activated protein kinases by a redox-sensitive mechanism in H4 rat hepatoma cells. Cancer Res 56: 2045–2051, 1996
Samet JM, Graves LM, Quay J, Dailey LA, Devlin RB, Ghio AJ, Wu W, Bromberg PA, Reed W: Activation of MAPKs in human bronchial epithelial cells exposed to metals. Am J Physiol 275: L551–L558, 1998
Wang Z, Templeton DM: Induction of c-fos proto-oncogene in mesangial cells by cadmium. J Biol Chem 273: 73–79, 1998
Hung JJ, Cheng TJ, Lai YK, Chang MD: Differential activation of p38 mitogen-activated protein kinase and extracellular signal-regulated protein kinases confers cadmium-induced HSP70 expression in 9L rat brain tumor cells. J Biol Chem 273: 31924–31931, 1998
Matsuoka M, Igisu H: Activation of c-Jun NH2-terminal kinase (JNK/SAPK) in LLC-PK1 cells by cadmium. Biochem Biophys Res Commun 251: 527–532, 1998
Chuang SM, Liou GY, Yang JL: Activation of JNK, p38 and ERK mitogen-activated protein kinases by chromium(VI) is mediated through oxidative stress but does not affect cytotoxicity. Carcinogenesis 21: 1491–1500, 2000
Chuang SM, Wang IC, Yang JL: Roles of JNK, p38 and ERK mitogenactivated protein kinases in the growth inhibition and apoptosis induced by cadmium. Carcinogenesis 21: 1423–1432, 2000
Yang PC, Luh KT, Wu R, Wu CW: Characterization of the mucin differentiation in human lung adenocarcinoma cell lines. Am J Respir Cell Mol Biol 7: 161–171, 1992
Hibi M, Lin A, Smeal T, Minden A, Karin M: Identification of an oncoprotein-and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev 7: 2135–2148, 1993
Kallunki T, Su B, Tsigelny I, Sluss HK, Dérijard B, Moore G, Davis R, Karin M: JNK2 contains a specificity-determining region responsible for efficient c-Jun binding and phosphorylation. Genes Dev 8: 2996–3007, 1994
Lin A, Minden A, Martinetto H, Claret FX, Lange-Carter C, Mercurio F, Johnson GL, Karin M: Identification of a dual specificity kinase that activates the Jun kinases and p38-Mpk2. Science 268: 286–290, 1995
Han J, Lee JD, Bibbs L, Ulevitch RJ: A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 265: 808–811, 1994
Huang S, Jiang Y, Li Z, Nishida E, Mathias P, Lin S, Ulevitch RJ, Nemerow GR, Han J: Apoptosis signaling pathway in T cells is composed of ICE/Ced-3 family proteases and MAP kinase kinase 6β. Immunity 6: 739–749, 1997
Lawler S, Cuenda A, Goedert M, Cohen P: SKK4, a novel activator of stress-activated protein kinase-1 (SAPK1/JNK). FEBS Lett 414: 153–158, 1997
Moriguchi T, Toyoshima F, Masuyama N, Hanafusa H, Gotoh Y, Nishida E: A novel SAPK/JNK kinase, MKK7, stimulated by TNFα and cellular stresses. EMBO J 16: 7045–7053, 1997
Keyse SM: Protein phosphatases and the regulation of mitogen-activated protein kinase signalling. Curr Opin Cell Biol 12: 186–192, 2000
Lee JC, Laydon JT, McDonnell PC, Gallagher TF, Kumar S, Green D, McNulty D, Blumenthal MJ, Heys JR, Landvatter SW, Strickler JE, McLaughlin MM, Siemens IR, Fisher SM, Livi GP, White JR, Adams JL, Young PR: A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372: 739–746, 1994
Cuenda A, Rouse J, Doza YN, Meier R, Cohen P, Gallagher TF, Young PR, Lee JC: SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett 364: 229–233, 1995
Foltz IN, Lee, JC, Young PR, Schrader JW: Hemopoietic growth factors with the exception of interleukin-4 activate the p38 mitogen-activated protein kinase pathway. J Biol Chem 272: 3296–3301, 1997
Ludwig S, Hoffmeyer A, Goebeler M, Kilian K, Hafner H, Neufeld B, Han J, Rapp UR: The stress inducer arsenite activates mitogen-activated protein kinases extracellular signal-regulated kinases 1 and 2 via a MAPK kinase 6/p38-dependent pathway. J Biol Chem 273: 1917–1922, 1998
Carter S, Auer KL, Reardon DB, Birrer M, Fisher PB, Valerie K, Schmidt-Ullrich R, Mikkelsen R, Dent P: Inhibition of the mitogen activated protein (MAP) kinase cascade potentiates cell killing by low dose ionizing radiation in A431 human squamous carcinoma cells. Oncogene 16: 2787–2796, 1998
Reardon DB, Contessa JN, Mikkelsen RB, Valerie K, Amir C, Dent P, Schmidt-Ullrich RK: Dominant negative EGFR-CD533 and inhibition of MAPK modify JNK1 activation and enhance radiation toxicity of human mammary carcinoma cells. Oncogene 18: 4756–4766, 1999
Sugiyama M, Wang XW, Costa M: Comparison of DNA lesions and cytotoxicity induced by calcium chromate in human, mouse, and hamster cell lines. Cancer Res 46: 4547–4551, 1986
Xu J, Bubley GJ, Detrick B, Blankenship LJ, Patierno SR: Chromium (VI) treatment of normal human lung cells results in guanine-specific DNA polymerase arrest, DNA-DNA crosslinks and S-phase blockade of cell cycle. Carcinogenesis 17: 1511–1517, 1996
Waalkes MP, Diwan BA, Weghorst CM, Ward JM, Rice JM, Cherian MG, Goyer RA: Further evidence of the tumor-suppressive effects of cadmium in the B6C3F1 mouse liver and lung: Late stage vulnerability of tumors to cadmium and the role of metallothionein. J Pharmacol Exp Ther 266: 1656–1663, 1993
Waalkes MP, Diwan BA: Cadmium-induced inhibition of the growth and metastasis of human lung carcinoma xenografts: Role of apoptosis. Carcinogenesis 20: 65–70, 1999
Liu ZG, Baskaran R, Lea-Chou ET, Wood LD, Chen Y, Karin M, Wang JYJ: Three distinct signalling responses by murine fibroblasts to genotoxic stress. Nature (Lond) 384: 273–276, 1996
Sanna MG, Duckett CS, Richter BWM, Thompson CB, Ulevitch RJ: Selective activation of JNK1 is necessary for the anti-apoptotic activity of hILP. Proc Natl Acad Sci USA 95: 6015–6020, 1998
Crawley JB, Rawlinson L, Lali FV, Page TH, Saklatvala J, Foxwell MJ: T cell proliferation in response to interleukins 2 and 7 requires p38 MAP kinase activation. J Biol Chem 272: 15023–15027, 1997
Simon C, Goepfert H, Boyd D: Inhibition of the p38 mitogen-activated protein kinase by SB 203580 blocks PMA-induced Mr 92,000 type IV collagenase secretion and in vitro invasion. Cancer Res 58: 1135–1139, 1998
Nemoto S, Xiang J, Huang S, Lin A: Induction of apoptosis by SB202190 through inhibition of p38β mitogen-activated protein kinase. J Biol Chem 273: 16415–16420, 1998
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chuang, S., Yang, J. Comparison of roles of three mitogen‐activated protein kinases induced by chromium(VI) and cadmium in non‐small‐cell lung carcinoma cells. Mol Cell Biochem 222, 85–95 (2001). https://doi.org/10.1023/A:1017967408266
Issue Date:
DOI: https://doi.org/10.1023/A:1017967408266